11 results
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
8 Jan 24
2 Strategy & Business Update J.P.Morgan Healthcare Conference 2024 Co - Founder, Board Co - Chair, President & Chief Executive Officer
6:30am
results for first patient dosed: Profoundly deaf child at baseline, demonstrates markedly improved hearing at 12 weeks post - treatment Intensity/volume
8-K
EX-99.2
ppbf7ecd
29 Jul 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99
0i6i6if3
10 Jun 10
Other Events
12:00am
- Prev
- 1
- Next